Long-term (three-month and one-year) follow-up of nasopharyngeal carriers of Neisseria meningitidis with a frequency of sample collection of once a week and once a month resp. in the healthy population with a mean age of 43 years revealed a 4.8% positivity (2 of 42 subjects). Carriership of the same phenotype and ET-genotype of the N. meningitidis group 29E was stable in one subject, while the other long-term carrier of N. meningitidis group B has changes of the phenotype as well as ET-genotype during the follow-up period. Double (after a 3-month interval) verification of the seroprevalence of specific antimeningococcal antibodies revealed in a group of immunized subjects (vaccine A and C) a considerable degree of anti A immunity. Anti A-seropositivity in subjects immunized within a three-year interval since vaccination was 100%, in those immunized within a four-year interval a decline to 66% was recorded. Anti C antibodies after vaccination within a three-year interval were recorded in 75% subjects, in vaccinated subjects the authors detected antibodies during the first year after vaccination in 86% of the subjects. Natural anti A antibodies of the lowest titre 1:6 were recorded in four non-vaccinated subjects (22%). Naturally acquired anti B antibodies (B:2a:P1.2,P1.5) and anti C (C:2a:P1.2,P1.5) were not detected in any of the subjects.

Download full-text PDF

Source

Publication Analysis

Top Keywords

anti antibodies
12
neisseria meningitidis
8
seroprevalence specific
8
subjects
8
meningitidis group
8
three-year interval
8
antibodies
6
anti
6
[long-term monitoring
4
monitoring neisseria
4

Similar Publications

Clinical Note: The evolution of interstitial cystic lung disease associated with anti-RNP antibodies - A decade-long observational case.

Pulmonology

December 2025

Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, Centre de Référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte d'Ile-de-France, Centre et Martinique. Service de Médecine Interne 2, Paris, France.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a systemic, progressive illness marked by persistent synovitis that causes substantial functional disability. Treatment delays frequently affect health-related quality of life. Extra-articular features are prevalent findings in RA, which leads to significant morbidity and mortality.

View Article and Find Full Text PDF

Objectives: To determine the features of rheumatoid pulmonary nodules and the factors associated with nodule progression in patients with rheumatoid arthritis.

Methods: Between January 2010 and September 2018, RA patients with at least one chest computed tomography (CT) were included. Two experienced radiologists examined chest CTs.

View Article and Find Full Text PDF

Functional characterization of novel anti-DEFA5 monoclonal antibody clones 1A8 and 4F5 in inflammatory bowel disease colitis tissues.

Inflamm Res

January 2025

Department of Biochemistry, Cancer Biology, Neuroscience, and Pharmacology, School of Medicine, Meharry Medical College, 1005 D.B. Todd Jr. Blvd, Nashville, TN, USA.

Background: The aberrant expression of α defensin 5 (DEFA5) protein in colonic inflammatory bowel diseases (IBDs) underlies the distinct pathogenesis of Crohn's colitis (CC). It can serve as a biomarker for differentiating CC from Ulcerative colitis (UC), particularly in Indeterminate colitis (IC) cases into UC and CC. We evaluated the specificity of commercially available anti-DEFA5 antibodies, emphasizing the need to further validate their appropriateness for a given application and highlighting the necessity for novel antibodies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!